Pulmonary embolism, coagulation

Aus coViki
(Unterschied zwischen Versionen)
Wechseln zu: Navigation, Suche
 
(20 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt)
Zeile 1: Zeile 1:
 
{{pnc}}
 
{{pnc}}
*[https://townhall.com/tipsheet/leahbarkoukis/2020/05/05/doctors-are-noticing-a-dangerous-phenomenon-even-after-wuhan-coronavirus-symptoms-are-gone-n2568192 thrombotic late reactions]
 
*[https://www.welt.de/wissenschaft/video207855067/Obduktionen-Corona-Patienten-sterben-haeufig-an-Blutgerinnseln.html german autopsy data]
 
{{tp|p=32331965|t=ä. Diagnosing Pulmonary Thromboembolism in COVID-19: A Stepwise Clinical and Imaging Approach |pdf=|usr=}}
 
{{tp|p=32312574|t=ä. COVID-19 pneumonia with hemoptysis: Acute segmental pulmonary emboli associated with novel coronavirus infection |pdf=|usr=}}
 
{{tp|p=32360384|t=ä. Acute Pulmonary Embolism in SARS-CoV-2 Infection Treated with Surgical Embolectomy |pdf=|usr=}}
 
{{tp|p=32305287|t=ä. Severe Acute Proximal Pulmonary Embolism and COVID-19: A Word of Caution |pdf=|usr=}}
 
{{tp|p=32360432|t=ä. Acute thrombosis of an aortic prosthetic graft in a patient with severe COVID-19  related pneumonia |pdf=|usr=}}
 
{{tp|p=32335249|t=ä. SARSCoV-2 infection and the upper limbs deep vein thrombosis risk |pdf=|usr=}}
 
{{tp|p=32350161|t=2020. Analysis of coagulation parameters in patients with COVID-19 in Shanghai, China |pdf=|usr=}}
 
{{tp|p=32281926|t=2020. COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET) |pdf=|usr=}}
 
{{tp|p=32250159|t=2020. Hemorrhagic Problem Among the Patients With COVID-19: Clinical Summary of 41 Thai Infected Patients |pdf=|usr=}}
 
{{tp|p=32357997|t=2020. Coagulopathy associated with COVID-19 |pdf=|usr=}}
 
{{tp|p=32334995|t=2020. Concomitant acute aortic thrombosis and pulmonary embolism complicating COVID-19  pneumonia |pdf=|usr=}}
 
{{tp|p=32303472|t=ä. Acute pulmonary embolism in a patient with COVID-19 pneumonia |pdf=|usr=}}
 
{{tp|p=32348233|t=2020. Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease |pdf=|usr=}}
 
{{tp|p=32227120|t=ä. Acute pulmonary embolism and COVID-19 pneumonia: a random association?|pdf=|usr=}}
 
{{tp|p=32338707|t=ä. Acute pulmonary embolism in conjunction with intramural right ventricular thrombus in a SARS-CoV-2-positive patient |pdf=|usr=}}
 
  
{{tp|p=32339717|t=ä. Pulmonary thromboembolism in criticall ill COVID-19 patients |pdf=|usr=}}
+
{{ft|D}}
{{tp|p=32367170|t=ä. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study |pdf=|usr=}}
+
Since there are many organ manifestations of Hypercoagulation, subcategorization and transcategorization was applied.
{{tp|p=32347323|t=ä. Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation |pdf=|usr=}}
+
{{tp|p=32328727|t=ä. Are subpleural consolidations indicators for segmental pulmonary embolism in COVID-19?|pdf=|usr=}}
+
{{tp|p=32322918|t=ä. Thrombotic events in SARS-CoV-2 patients: an urgent call for ultrasound screening |pdf=|usr=}}
+
  
{{tp|p=32311448|t=ä. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up |pdf=|usr=}}
+
*'''[[Venous thrombosis]]'''
{{tp|p=32212240|t=2020. Disseminated intravascular coagulation in patients with 2019?nCoV pneumonia |pdf=|usr=}}
+
*'''[[Pulmonary embolism]]'''
{{tp|p=32073213|t=2020. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia |pdf=|usr=}}
+
*'''[[Cerebral embolism]]'''
{{tp|p=32372336|t=ä. Pulmonary intravascular coagulation in COVID-19: possible pathogenesis and recommendations on anticoagulant/thrombolytic therapy |pdf=|usr=}}
+
*'''[[Myocardial infarction]]'''
{{tp|p=32367471|t=ä. Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies |pdf=|usr=}}
+
*'''[[Arterial embolism]]'''
{{tp|p=32338320|t=ä. Covid-19 treatment update: follow the scientific evidence |pdf=|usr=}}
+
*'''[[Microembolism]]'''
{{tp|p=32246317|t=ä. Difference of coagulation features between severe pneumonia induced by SARS-CoV2  and non-SARS-CoV2 |pdf=|usr=}}
+
*'''[[Hypercoagulation]]'''
{{tp|p=32306290|t=ä. Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very  severe patient with 2019 novel coronavirus disease: a case report |pdf=|usr=}}
+
*'''[[Antiphospholipid antibodies]]'''
{{tp|p=32330267|t=ä. Pulmonary embolism in returning traveler with COVID-19 pneumonia |pdf=|usr=}}
+
*'''[[Disseminated intravascular coagulation]]'''
{{tp|p=32360371|t=ä. Thromboembolic events in patients with SARS-CoV-2 |pdf=|usr=}}
+
*'''[[Bleeding]]'''
{{tp|p=32360679|t=ä. Acute limb ischemia in patients with COVID-19 pneumonia |pdf=|usr=}}
+
*'''[[Labwork of Thrombembolism]]'''
{{tp|p=32305586|t=ä. Upsurge of deep venous thrombosis in patients affected by COVID-19: Preliminary data and possible explanations |pdf=|usr=}}
+
*'''[[Prophylaxis of Thrombembolism]]'''
{{tp|p=32360372|t=ä. An increased severity of peripheral arterial disease in the covid-19 era |pdf=|usr=}}
+
{{tp|p=32361070|t=2020. Cardiovascular examination should also include peripheral arterial evaluation for COVID-19 patients |pdf=|usr=}}
+
{{tp|p=32313884|t=ä. COVID-19 Complicated by Acute Pulmonary Embolism and Right-Sided Heart Failure |pdf=|usr=}}
+
  
{{tp|p=32330428|t=ä. Hospital-based use of thromboprophylaxis in patients with COVID-19 |pdf=|usr=}}
+
The unifying concept behind is '''[[Dysendotheliopathies]]''' with the components Coagulation /Microthrombi, proliferative or cytopathic obstructive Endotheliosis and mediator production as well as failure of the mitigating systems and secondary vasculitis.
{{tp|p=32268022|t=ä. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19 |pdf=|usr=}}
+
  
{{tp|p=32356640|t=2020. SARS-CoV-2 pneumonia and pulmonary embolism in a 66-year-old female |pdf=|usr=}}
 
{{tp|p=32329980|t=2020. SARS-CoV-2 infection masquerading as a possible pulmonary embolism |pdf=|usr=}}
 
{{tp|p=32351657|t=ä. Arterial and venous abdominal thrombosis in a 79-year-old woman with COVID-19 pneumonia |pdf=|usr=}}
 
{{tp|p=32353746|t=2020. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy |pdf=|usr=}}
 
{{tp|p=32335420|t=ä. Age-adjusted D-dimer cut-off levels to rule out venous thromboembolism in COVID-19 patients |pdf=|usr=}}
 
{{tp|p=32371163|t=ä. Pulmonary embolism in a young pregnant woman with Covid-19 |pdf=|usr=}}
 
{{tp|p=32361513|t=ä. Where do we stand with antithrombotic prophylaxis in patients with COVID-19?|pdf=|usr=}}
 
{{tp|p=32302782|t=2020. Pulmonary embolism in patients with COVID-19: Time to change the paradigm of computed tomography |pdf=|usr=}}
 
{{tp|p=C7146714|t=ä. Incidence of thrombotic complications in critically ill ICU patients with COVID-19 |pdf=|usr=}}
 
  
{{tp|p=32267008|t=2020. Critically ill COVID-19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability |pdf=|usr=}}
 
{{tp|p=32374815|t=ä. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study |pdf=|usr=}}
 
  
{{tp|p=32339221|t=2020. COVID-19 and its implications for thrombosis and anticoagulation |pdf=|usr=}}
+
----
{{tp|p=32374029|t=2020. Arterial thromboembolic complications in COVID-19 in low-risk patients despite prophylaxis |pdf=|usr=}}
+
{{tp|p=32369614|t=2020. Concomitant haemorrhagic syndrome and recurrent extensive arterial thrombosis in  a patient with COVID-19 and acute promyelocytic leukaemia |pdf=|usr=}}
+
{{ttp|p=32369610|t=2020. Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily |pdf=|usr=}}
+
{{tp|p=32353183|t=2020. Acute aorto-iliac and mesenteric arterial thromboses as presenting features of COVID-19 |pdf=|usr=}}
+
{{ttp|p=32330308|t=2020. COVID19 coagulopathy in Caucasian patients |pdf=|usr=}}
+
{{ttp|p=32304581|t=2020. Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis |pdf=|usr=}}
+
{{tp|p=32304577|t=2020. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action |pdf=|usr=}}
+
{{tp|p=32352633|t=2020. Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients |pdf=|usr=}}
+
{{tp|p=32339025|t=2020. Why Fibrinolytic Therapy for STEMI in The COVID-19 Pandemic is Not Your New Best  Friend |pdf=|usr=}}
+
  
{{tp|p=32330083|t=2020. Pulmonary Embolism in COVID-19 Patients: Awareness of an Increased Prevalence |pdf=|usr=}}
+
*'''papers on various thromboembolic manifestations'''
{{tp|p=32172226|t=2020. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection |pdf=|usr=}}
+
{{tp|p=32281926|t=2020. COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET) |pdf=|usr=}}
{{tp|p=32333581|t=2020. Contrast enhanced ultrasonography (CEUS) to detect abdominal microcirculatory disorders in severe cases of COVID-19 infection: First experience |pdf=|usr=}}
+
{{tp|p=32347323|t=ä. Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation |pdf=|usr=}}
{{tp|p=32333579|t=2020. (clin-hemorheol-microcirc) COVID-19 |pdf=|usr=}}
+
{{tp|p=32360371|t=ä. Thromboembolic events in patients with SARS-CoV-2 |pdf=|usr=}}
{{ttp|p=32294809|t=2020. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis |pdf=|usr=}}
+
{{tp|p=C7146714|t=ä. Incidence of thrombotic complications in critically ill ICU patients with COVID-19 |pdf=|usr=}}
{{tp|p=32374381|t=ä. Large saddle pulmonary embolism in a woman infected by COVID-19 pneumonia |pdf=|usr=}}
+
{{tp|p=32324101|t=2020. Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands |pdf=|usr=}}
 +
{{tp|p=32133825|t=2020. Characteristics, causes, diagnosis and treatment of coagulation dysfunction in patients with COVID-19  |pdf=|usr=}}
 +
{{tp|p=32402423|t=2020. Ten key points that vascular doctors learned very quickly about COVID-19 |pdf=|usr=}}
 +
{{tp|p=32381264|t=2020. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis |pdf=|usr=}}
 +
{{tp|p=32388068|t=2020. Thrombotic complications in critically ill patients with COVID 19 |pdf=|usr=}}
 +
{{tp|p=32291094|t=2020. Incidence of thrombotic complications in critically ill ICU patients with COVID-19 |pdf=|usr=}}
 +
{{tp|p=32374544|t=2020. Risque thrombotique veineux induit par le SARS-CoV-2 : prevalence, recommandations et perspectives |pdf=|usr=}}
 +
*[https://townhall.com/tipsheet/leahbarkoukis/2020/05/05/doctors-are-noticing-a-dangerous-phenomenon-even-after-wuhan-coronavirus-symptoms-are-gone-n2568192 thrombotic late reactions]
  
{{tp|p=32311843|t=2020. Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2 |pdf=|usr=}}
 
{{ttp|p=32349055|t=2020. Is COVID Evolution Due to Occurrence of Pulmonary Vascular Thrombosis?|pdf=|usr=}}
 
{{tp|p=32379935|t=2020. Response to "Lupus anticoagulant is frequent in patients with Covid-19" |pdf=|usr=}}
 
{{tp|p=32379918|t=2020. Coagulopathy of COVID-19 and antiphospholipid antibodies |pdf=|usr=}}
 
{{tp|p=32369666|t=2020. Incidence of venous thromboembolism in hospitalized patients with COVID-19 |pdf=|usr=}}
 
{{tp|p=32239799|t=2020. The versatile heparin in COVID-19 |pdf=|usr=}}
 
{{tp|p=32338827|t=2020. ISTH interim guidance on recognition and management of coagulopathy in COVID-19 |pdf=|usr=}}
 
{{tp|p=32302462|t=2020. ISTH interim guidance on recognition and management of coagulopathy in COVID-19:  A Comment |pdf=|usr=}}
 
{{tp|p=32302442|t=2020. RE: ISTH interim guidance to recognition and management of coagulopathy in COVID-19 |pdf=|usr=}}
 
{{tp|p=32220112|t=2020. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy |pdf=|usr=}}
 
{{tp|p=32302451|t=2020. Response to  Reply to Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy  |pdf=|usr=}}
 
{{tp|p=32302438|t=2020. Hypercoagulability of COVID-19 patients in Intensive Care Unit  A Report of Thromboelastography Findings and other Parameters of Hemostasis |pdf=|usr=}}
 
{{tp|p=32271988|t=2020. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia |pdf=|usr=}}
 
{{tp|p=32344457|t=2020. Uncertainties on the prognostic value of D-dimers in COVID-19 patients |pdf=|usr=}}
 
{{ttp|p=32329231|t=2020. Direct oral anticoagulant plasma levels  striking increase in severe COVID-19 respiratory syndrome patients treated with antiviral agents: The Cremona experience |pdf=|usr=}}
 
{{tp|p=32329221|t=2020. Type and dose of heparin in Covid-19: Reply |pdf=|usr=}}
 
{{tp|p=32329246|t=2020. Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19 |pdf=|usr=}}
 
{{tp|p=32324960|t=2020. Laboratory haemostasis monitoring in COVID-19 |pdf=|usr=}}
 
{{tp|p=32324958|t=2020. Lupus anticoagulant is frequent in patients with Covid-19 |pdf=|usr=}}
 
{{tp|p=32320517|t=2020. High incidence of venous thromboembolic events in anticoagulated severe COVID-19  patients |pdf=|usr=}}
 
{{tp|p=32306492|t=2020. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19 |pdf=|usr=}}
 
{{tp|p=32302456|t=2020. Potential of heparin and nafamostat combination therapy for COVID-19 |pdf=|usr=}}
 
{{tp|p=32302459|t=2020. COVID-19 and acute coagulopathy in pregnancy |pdf=|usr=}}
 
{{tp|p=32302453|t=2020. Thromboinflammation and the hypercoagulability of COVID-19 |pdf=|usr=}}
 
{{ttp|p=32302448|t=2020. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome |pdf=|usr=}}
 
{{tp|p=32294321|t=2020. Impact of the COVID-19 pandemic on therapeutic choices in thrombosis-hemostasis |pdf=|usr=}}
 
{{tp|p=32294295|t=2020. Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19 |pdf=|usr=}}
 
{{tp|p=32294289|t=2020. Venous thromboembolism in COVID-19 patients |pdf=|usr=}}
 
{{tp|p=32293083|t=2020. Pulmonary thrombosis in 2019-nCoV pneumonia?|pdf=|usr=}}
 
{{tp|p=32282993|t=2020. DOACs and  newer  haemophilia therapies in COVID-19 |pdf=|usr=}}
 
{{tp|p=32281766|t=2020. Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome?|pdf=|usr=}}
 
  
 +
----
 +
 +
*'''papers on Hypoxemia'''
 
{{tp|p=32359410|t=ä. Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT |pdf=|usr=}}
 
{{tp|p=32359410|t=ä. Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT |pdf=|usr=}}
{{tp|p=32369280|t=ä. Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19 |pdf=|usr=}}
+
{{tp|p=C7177114|t=2020. Hypoxia in COVID-19: Sign of Severity or Cause for Poor Outcomes |pdf=|usr=}}
{{tp|p=32374956|t=2020. Acute Cor Pulmonale in Critically Ill Patients with Covid-19 |pdf=|usr=}}
+
{{tp|p=32376101|t=2020. Association Between Hypoxemia and Mortality in Patients With COVID-19 |pdf=|usr=}}
  
{{tp|p=32367765|t=2020. Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count |pdf=|usr=}}
 
{{tp|p=32367749|t=2020. Transient appearance of EDTA dependent pseudothrombocytopenia in a patient with 2019 novel coronavirus pneumonia |pdf=|usr=}}
 
{{tp|p=32376225|t=ä. Pulmonary embolism in COVID-19  When nothing is what it seems |pdf=|usr=}}
 
{{tp|p=32324101|t=2020. Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands |pdf=|usr=}}
 
{{tp|p=32324103|t=2020. Acute Pulmonary Embolism Associated with COVID-19 Pneumonia Detected by Pulmonary CT Angiography |pdf=|usr=}}
 
{{tp|p=32324102|t=2020. Acute Pulmonary Embolism in COVID-19 Patients on CT Angiography and Relationship  to D-Dimer Levels |pdf=|usr=}}
 
{{tp|p=32324099|t=2020. Pulmonary, Cerebral, and Renal Thromboembolic Disease Associated with COVID-19 Infection |pdf=|usr=}}
 
{{tp|p=32374544|t=2020. Risque thrombotique veineux induit par le SARS-CoV-2 : prevalence, recommandations et perspectives |pdf=|usr=}}
 
{{tp|p=32378030|t=ä. COVID-19-Related Stroke |pdf=|usr=}}
 
{{tp|p=32279286|t=2020. Recommendations for Minimal Laboratory Testing Panels in Patients with COVID-19:  Potential for Prognostic Monitoring |pdf=|usr=}}
 
{{tp|p=32349133|t=2020. Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge |pdf=|usr=}}
 
{{tp|p=32349132|t=2020. Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to  Use High-Dose Heparin for Thromboprophylaxis Justified?|pdf=|usr=}}
 
{{tp|p=32316065|t=2020. Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines |pdf=|usr=}}
 
{{tp|p=32316063|t=2020. COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure |pdf=|usr=}}
 
{{tp|p=32374920|t=2020. Viscoelastic testing in COVID-19: a possible screening tool for severe disease?|pdf=|usr=}}
 
{{tp|p=32220276|t=2020.  Clinical and coagulation characteristics of 7 patients with critical COVID-2019  pneumonia and acro-ischemia  |pdf=|usr=}}
 
{{tp|p=32133825|t=2020.  Characteristics, causes, diagnosis and treatment of coagulation dysfunction in patients with COVID-19  |pdf=|usr=}}
 
{{tp|p=32133824|t=2020.  COVID-19 complicated with DIC: 2 cases report and literatures review  |pdf=|usr=}}
 
{{tp|p=32283877|t=2020.  Prognostic value of myocardial injury in patients with COVID-19  |pdf=|usr=}}
 
{{tp|p=32344469|t=2020. DIC in COVID-19: Implications for Prognosis and Treatment?|pdf=|usr=}}
 
{{tp|p=32267998|t=2020. Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series |pdf=|usr=}}
 
{{tp|p=32378044|t=ä. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized  patients: comment |pdf=|usr=}}
 
  
{{tp|p=32418867|t=ä. COVID-19 associated coagulopathy: The crowning glory of thrombo-inflammation concept |pdf=|usr=}}
+
----
{{tp|p=C7196387|t=ä. Extensive aortic thrombosis in a patient with Covid-19 |pdf=|usr=}}
+
{{tp|p=32386987|t=ä. Tromboembolia pulmonar aguda y enfermedad por coronavirus (COVID-19): una asociacion frecuente en pacientes graves?|pdf=|usr=}}
+
{{tp|p=32414639|t=ä. Bleeding in COVID-19 severe pneumonia: The other side of abnormal coagulation pattern?|pdf=|usr=}}
+
  
{{tp|p=32378044|t=ä. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment |pdf=|usr=}}
+
*'''others'''
{{ttp|p=32387623|t=ä. Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 |pdf=|usr=}}
+
{{tp|p=32462990|t=2020. COVID-19 complicated by pulmonary embolism treated with catheter directed thrombectomy.|pdf=|usr=007}}
{{tp|p=C7183940|t=ä. Proposal of the French Society of Vascular Medicine for the prevention, diagnosis and treatment of venous thromboembolic disease in outpatients with COVID-19 |pdf=|usr=}}
+
{{tp|p=32338320|t=ä. Covid-19 treatment update: follow the scientific evidence |pdf=|usr=}}
{{tp|p=32402423|t=2020. Ten key points that vascular doctors learned very quickly about COVID-19 |pdf=|usr=}}
+
{{tp|p=32501145|t=2020. Venous thromboembolism in patients with COVID-19 (SARS-CoV-2 infection) - a position paper of the German Society of Angiology (DGA).|pdf=|usr=007}}
{{tp|p=32417015|t=ä. Risk of peripheral arterial thrombosis in COVID-19 |pdf=|usr=}}
+
{{tp|p=32459857|t=2020. D-dimer and mortality in COVID-19: a self-fulfilling prophecy or a pathophysiological clue?|pdf=|usr=007}}
{{tp|p=32423583|t=2020. Acute limb ischaemia in two young, non-atherosclerotic patients with COVID-19 |pdf=|usr=}}
+
{{tp|p=32314950|t=2020. Society for Vascular Medicine (SVM) Leaders Respond to the COVID-19 Crisis.|pdf=|usr=007}}
 +
{{tp|p=32447301|t=2020. Coexistent COVID-19 pneumonia and pulmonary embolism: challenges in identifying dual pathology.|pdf=|usr=007}}
 +
{{tp|p=32455440|t=2020. Sars-CoV-2 Induced Coagulopathy and Prognosis in Hospitalized Patients: A Snapshot from Italy.|pdf=|usr=007}}
 +
{{tp|p=32396963|t=2020. SARS-2 Coronavirus-Associated Hemostatic Lung Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary Embolism?|pdf=|usr=007}}
 +
{{tp|p=32512587|t=2020. Bleeding and Bleeding Risk in COVID-19.|pdf=|usr=007}}
 +
{{tp|p=32463186|t=2020. Lungeembolisme ved covid-19.|pdf=|usr=007}}
 +
{{tp|p=32425013|t=2020. COVID-19 and coagulative axis: review of emerging aspects in a novel disease.|pdf=|usr=007}}
 +
{{tp|p=32469410|t=2020. Venous Thrombosis Among Critically Ill Patients With Coronavirus Disease 2019 (COVID-19).|pdf=|usr=007}}
 +
{{tp|p=32392741|t=2020. Clotting Factors in COVID-19: Epidemiological Association and Prognostic Values in Different Clinical Presentations in an Italian Cohort.|pdf=|usr=007}}
 +
{{tp|p=32447934|t=2020. [Clinical and coagulation characteristics in 7 patients with critical COVID-2019 pneumonia and acro-ischemia].|pdf=|usr=007}}
 +
{{tp|p=32395964|t=2020. Do's-and-don'ts bij COVID-19-coagulopathie.|pdf=|usr=007}}
 +
{{tp|p=32454268|t=2020. D-dimer in patients infected with COVID-19 and suspected pulmonary embolism.|pdf=|usr=007}}
 +
{{tp|p=32507399|t=2020. Tromboembolismo pulmonar y COVID-19: un cambio de paradigma.|pdf=|usr=007}}
 +
{{tp|p=32380898|t=2020. The "venous perspective" in Lombardia (Italy) during the first weeks of the COVID-19 epidemic.|pdf=|usr=007}}
 +
{{tp|p=32490886|t=2020. Is there a rationale for heparin use among severe COVID-19 patients?|pdf=|usr=007}}
 +
{{tp|p=32453702|t=2020. Procoagulatio, hypercoagulatio es fibrinolysis "shut down" kimutatasa ClotPro(R) viszkoelasztikus tesztek segitsegevel COVID-19-betegekben.|pdf=|usr=007}}
 +
{{tp|p=32427809|t=2020. Inflammatory and Coagulative Considerations for the Management of Orthopaedic Trauma Patients with COVID-19: A Review of the Current Evidence and Our Surgical Experience.|pdf=|usr=007}}
 +
{{tp|p=32426897|t=2020. Heparin - an old drug with multiple potential targets in Covid-19 therapy.|pdf=|usr=007}}
 +
{{tp|p=32415902|t=2020. Ibuprofen and thromboembolism in SARS-COV2.|pdf=|usr=007}}
 +
{{tp|p=32506364|t=2020. Hyperacute multi-organ thromboembolic storm in COVID-19: a case report.|pdf=|usr=007}}
 +
{{tp|p=32504449|t=2020. Diagnosis of venous and arterial thromboembolic events in COVID-19 virus-infected patients.|pdf=|usr=007}}
 +
{{tp|p=32464707|t=2020. Macrothrombosis and stroke in patients with mild Covid-19 infection.|pdf=|usr=007}}
 +
{{tp|p=32470213|t=2020. All those D-dimers in COVID-19.|pdf=|usr=007}}
 +
{{tp|p=32470207|t=2020. Frequency of lupus anticoagulant in Covid-19 patients.|pdf=|usr=007}}
 +
{{tp|p=32470198|t=2020. Clinical differentiation of anticoagulant and non-anticoagulant properties of heparin.|pdf=|usr=007}}
 +
{{tp|p=32470154|t=2020. Reply to 'Ibuprofen and thromboembolism in SARS-COV2'.|pdf=|usr=007}}
 +
{{tp|p=32470156|t=2020. The novel coronavirus disease (COVID-19) complicated by pulmonary embolism and acute respiratory distress syndrome.|pdf=|usr=007}}
 +
{{tp|p=32393875|t=2020. Coronavirus blood-clot mystery intensifies.|pdf=|usr=007}}
 +
{{tp|p=32497287|t=2020. Anticardiolipin antibodies and COVID-19-A case report from America.|pdf=|usr=007}}
 +
{{tp|p=32495985|t=2020. The association between D-dimers in COVID-19 patients and mortality remains beset of uncertainties.|pdf=|usr=007}}
 +
{{tp|p=32409435|t=2020. Coagulopathy in COVID-19.|pdf=|usr=007}}
 +
{{tp|p=32505779|t=2020. Could antiphospholipid antibodies contribute to coagulopathy in COVID-19?|pdf=|usr=007}}
 +
{{tp|p=32512349|t=2020. Clinically significant anticardiolipin antibodies associated with COVID-19.|pdf=|usr=007}}
 +
{{tp|p=32468942|t=2020. A matter of time: duration and choice of venous thromboprophylaxis in patients diagnosed with COVID-19.|pdf=|usr=007}}
 +
{{tp|p=32464676|t=2020. Haemostasis in Times of COVID-19.|pdf=|usr=007}}
 +
{{tp|p=32498097|t=2020. Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis.|pdf=|usr=007}}
 +
{{tp|p=32476551|t=2020. Challenges in COVID-19: is pulmonary thromboembolism related to overall severity?|pdf=|usr=007}}
 +
{{tp|p=32429774|t=2020. Anti-coagulant and anti-platelet therapy in the COVID-19 patient: a best practices quality initiative across a large health system.|pdf=|usr=007}}
 +
{{tp|p=32508034|t=2020. Predicted value of coagulation function for prognosis and admission time to negative RT-PCR detection in non-critical COVID-19 patients.|pdf=|usr=007}}
 +
{{ttp|p=32508062|t=2020. COVID-19 critical illness pathophysiology driven by diffuse pulmonary thrombi and pulmonary endothelial dysfunction responsive to thrombolysis.|pdf=|usr=007}}
 +
{{tp|p=32432563|t=2020. Reporting of D-dimer data in COVID-19: some confusion and potential for misinformation.|pdf=|usr=007}}
 +
{{tp|p=32421381|t=2020. Deep Vein Thrombosis in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: Prevalence, Risk Factors, and Outcome.|pdf=|usr=007}}
 +
{{tp|p=32412320|t=2020. Extremely High Incidence of Lower Extremity Deep Venous Thrombosis in 48 Patients with Severe COVID-19 in Wuhan.|pdf=|usr=007}}
 +
{{tp|p=32508261|t=2020. Hypoalbuminemia, Coagulopathy and Vascular Disease in Covid-19.|pdf=|usr=007}}
 +
{{tp|p=32463538|t=2020. Excess out-of-hospital deaths during COVID-19 outbreak: evidence of pulmonary embolism as a main determinant.|pdf=|usr=007}}
 +
{{tp|p=32406381|t=2020. COVID-19: progression of disease and intravascular coagulation - present status and future perspectives.|pdf=|usr=007}}
 +
{{tp|p=32423903|t=2020. Thrombotic risk in COVID-19: a case series and case-control study.|pdf=|usr=007}}
 +
{{tp|p=32491074|t=2020. COVID-19 e Estado de Hipercoagulabilidade: Uma Nova Perspectiva Terapeutica.|pdf=|usr=007}}
 +
{{tp|p=32396903|t=2020. Venous Thromboembolism Complicated with COVID-19: What Do We Know So Far?|pdf=|usr=007}}
 +
{{tp|p=32500589|t=2020. Superficial thrombophlebitis in a patient with COVID 19: Heparin treatment after evaluation of D - Dimer: COVID 19 and Superficial thrombophlebitis.|pdf=|usr=007}}
 +
{{ttp|p=32459672|t=2020. Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019.|pdf=|usr=007}}
 +
{{tp|p=32503799|t=2020. Abrupt deterioration and pulmonary embolism in COVID-19: a case report.|pdf=|usr=007}}
 +
{{tp|p=32452757|t=2020. Vascular injury and COVID-19-related mortality: What lies below the tip of the iceberg?|pdf=|usr=007}}
 +
{{tp|p=32512408|t=2020. The choice of intravenous thrombolysis for Acute Ischemic Stroke under COVID-19 infection.|pdf=|usr=007}}
 +
{{tp|p=32453688|t=2020. COVID-19, thromboembolic risk and thromboprophylaxis: learning lessons from the bedside, awaiting evidence.|pdf=|usr=007}}
 +
{{tp|p=32438458|t=2020. Molecular mechanisms for thrombosis risk in Black people: a role in excess mortality from COVID-19.|pdf=|usr=007}}
 +
{{tp|p=32425273|t=2020. Pulmonary embolism and Sars-Cov-2 infection: A new indication for surgical pulmonary endarterectomy?|pdf=|usr=008}}
 +
{{tp|p=32420615|t=2020. Dynamic relationship between D-dimer and COVID-19 severity.|pdf=|usr=007}}
 +
{{tp|p=32510975|t=2020. Thromboprophylaxis in COVID-19: Anti-FXa - The Missing Factor?|pdf=|usr=007}}
 +
{{tp|p=32383969|t=2020. Segmental Pulmonary Vascular Changes in COVID-19 Pneumonia.|pdf=|usr=007}}
 +
{{tp|p=32478611|t=2020. Reply to "Segmental Pulmonary Vascular Changes in COVID-19 Pneumonia".|pdf=|usr=007}}
 +
{{tp|p=32506683|t=2020. D-dimer triage for COVID-19.|pdf=|usr=007}}
 +
{{tp|p=32484901|t=2020. Re The source of elevated plasma D-dimer levels in COVID-19 infection.|pdf=|usr=007}}
 +
{{tp|p=32497248|t=2020. Pulmonary Artery Thrombectomy - A Life Saving Treatment in a Patient with Presumed COVID-19 complicated by a massive Pulmonary Embolus.|pdf=|usr=007}}
 +
{{tp|p=32484907|t=2020. Prevalence of Venous Thromboembolism in Critically Ill Patients with COVID-19.|pdf=|usr=007}}
 +
{{tp|p=32420614|t=2020. First COVID-19 maternal mortality in the UK associated with thrombotic complications.|pdf=|usr=007}}
 +
{{tp|p=32439704|t=2020. Covid-19 and thrombosis: what do we know about the risks and treatment?|pdf=|usr=007}}
 +
{{tp|p=32462179|t=2020. Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study.|pdf=|usr=007}}
 +
{{tp|p=32492712|t=2020. COVID and Coagulation: Bleeding and Thrombotic Manifestations of SARS-CoV2 Infection.|pdf=|usr=007}}
 +
{{tp|p=32425236|t=2020. Acute Pulmonary Embolism: An unseen villain in COVID-19.|pdf=|usr=008}}
 +
{{tp|p=32532932|t=2020. Should lCU COVID-19 patients empirically receive therapeutic doses of anticoagulant?|pdf=|usr=008}}
 +
{{tp|p=32532939|t=2020. The rationale for Low-Molecular Weight Heparin (LMWH) use in SARS-CoV-2 infection|pdf=|usr=008}}
 +
{{tp|p=32532948|t=2020. Clinical experience with therapeutic dose of Low-Molecular-Weight Heparin.|pdf=|usr=008}}
 +
{{tp|p=32497796|t=2020. Combination of thrombolytic and immunosuppressive therapy for coronavirus disease 2019: A case report.|pdf=|usr=008}}
 +
{{tp|p=32471650|t=2020. Acute pulmonary embolism in COVID-19 disease: Preliminary report on seven patients.|pdf=|usr=008}}
 +
{{tp|p=32435822|t=2020. Incidence of pulmonary embolism in patients with COVID-19.|pdf=|usr=008}}
 +
{{tp|p=32435823|t=2020. Prothrombotic phenotype in COVID-19 severe patients.|pdf=|usr=008}}
 +
{{tp|p=32405288|t=2020. Acute upper limb ischemia in a patient with COVID-19.|pdf=|usr=008}}
 +
{{tp|p=32440985|t=2020. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment.|pdf=|usr=008}}
 +
{{tp|p=32424482|t=2020. Systemic arterial thrombosis and acute mesenteric ischemia in a patient with COVID-19.|pdf=|usr=008}}
 +
{{tp|p=32415314|t=2020. Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19.|pdf=|usr=008}}
 +
{{tp|p=32447121|t=2020. Unheralded Lower Limb Threatening Ischemia in a COVID-19 Patient.|pdf=|usr=008}}
 +
{{ttp|p=32422349|t=2020. Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection.|pdf=|usr=008}}
 +
{{tp|p=32514682|t=2020. Managing anticoagulation in the COVID-19 era between lockdown and reopening phases.|pdf=|usr=008}}
 +
{{tp|p=32504198|t=2020. The burden of thrombotic complications in critically ill patients with COVID-19: charting the uncharted.|pdf=|usr=008}}
 +
{{tp|p=32490908|t=2020. COVID-19 pneumonia: a risk factor for pulmonary thromboembolism?|pdf=|usr=008}}
 +
{{tp|p=32521707|t=2020. Non-Overt Coagulopathy in Non-ICU Patients with Mild to Moderate COVID-19 Pneumonia.|pdf=|usr=008}}
 +
{{tp|p=32479784|t=2020. High prevalence of deep vein thrombosis in mechanically ventilated COVID-19 patients.|pdf=|usr=008}}
 +
{{tp|p=32414622|t=2020. Intravenous Thrombolysis for Stroke in a COVID-19 Positive Filipino Patient, a Case Report.|pdf=|usr=008}}
 +
{{tp|p=32402522|t=2020. Prophylactic anticoagulant therapy for reducing the risk of stroke and other thrombotic events in COVID-19 patients.|pdf=|usr=008}}
 +
{{tp|p=32305883|t=2020. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past.|pdf=|usr=008}}
 +
{{tp|p=32362977|t=2020. Abnormal Hemostatic Parameters and Risk of Thromboembolism Among Patients With COVID-19 Infection.|pdf=|usr=008}}
 +
{{tp|p=32504450|t=2020. Dysfunctional Coagulation in COVID-19: From Cell to Bedside.|pdf=|usr=008}}
 +
{{tp|p=32452874|t=2020. Thrombosis and coagulopathy in COVID-19 patients requiring extracorporeal membrane oxygenation.|pdf=|usr=008}}
 +
{{tp|p=32474145|t=2020. COVID-19-Related Aortic Thrombosis: A Report of Four Cases.|pdf=|usr=008}}
 +
{{tp|p=32473304|t=2020. Abdominal Aortic Thrombosis Complicating COVID-19 Pneumonia.|pdf=|usr=008}}
 +
{{tp|p=32473303|t=2020. Inferior vena cava filter in a patient with COVID-19 pneumonia to prevent a massive pulmonary embolism.|pdf=|usr=008}}
 +
{{tp|p=32440663|t=2020. Pulmonary Thromboembolism as a Potential Cause of Clinical Deterioration in COVID-19 Patients; a Commentary.|pdf=|usr=008}}
 +
{{tp|p=32422061|t=2020. Thromboembolic Findings in COVID-19 Autopsies: Pulmonary Thrombosis or Embolism?|pdf=|usr=008}}
 +
{{tp|p=32422076|t=2020. Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series.|pdf=|usr=008}}
 +
{{tp|p=32425319|t=2020. COVID-19 infection with extensive thrombosis: A case of phlegmasia cerulea dolens.|pdf=|usr=008}}
 +
{{tp|p=32492443|t=2020. Right-to-left interatrial shunt in COVID-19 patients with pulmonary embolism.|pdf=|usr=008}}
 +
{{tp|p=32437961|t=2020. Coagulation changes and thromboembolic risk in COVID-19 pregnant patients.|pdf=|usr=008}}
 +
{{tp|p=32437586|t=2020. Understanding the COVID-19 coagulopathy spectrum.|pdf=|usr=008}}
 +
{{tp|p=32426575|t=2020. Clot in Transit on Transesophageal Echocardiography in a Prone Patient with COVID-19 Acute Respiratory Distress Syndrome.|pdf=|usr=008}}
 +
{{tp|p=32468143|t=2020. Heparin-Related Major Bleeding in Covid-19-Positive Patient: Perspective from the Outbreak.|pdf=|usr=008}}
 +
{{tp|p=32419077|t=2020. Spontaneous Bleedings in COVID-19 Patients: An Emerging Complication.|pdf=|usr=008}}
 +
{{tp|p=32417209|t=2020. Thrombocytopenia and coagulation disorders due to COVID 19 infection with concomitant cardiovascular diseases requiring anti-platelet and anticoagulant therapy, which strategy?|pdf=|usr=008}}
 +
{{tp|p=32516478|t=2020. Severe bleeding in a patient with Factor XIII deficiency and COVID-19.|pdf=|usr=008}}
 +
{{tp|p=32301349|t=2020. Cost-effectiveness of rivaroxaban plus aspirin (dual pathway inhibition) for prevention of ischaemic events in patients with cardiovascular disease: on top optimisation of secondary prevention medication in the context of COVID-19 pandemia.|pdf=|usr=008}}
 +
{{tp|p=32445671|t=2020. Can Ticagrelor be used to prevent sepsis-induced coagulopathy in COVID-19?|pdf=|usr=008}}
 +
{{tp|p=32400024|t=2020. More on COVID-19 coagulopathy in Caucasian patients.|pdf=|usr=008}}
 +
{{tp|p=32392353|t=2020. More on: 'COVID-19 coagulopathy in Caucasian patients'.|pdf=|usr=008}}
 +
{{tp|p=32500226|t=2020. Antiphospholipid antibodies in patient with acute lower member ischemia and pulmonary thromboembolism as a result of infection by SARS-CoV2.|pdf=|usr=008}}
 +
{{tp|p=32529774|t=2020. High Frequency of Antiphospholipid Antibodies in Critically-ill COVID-19 Patients: a Link with Hypercoagulability?|pdf=|usr=008}}
 +
{{tp|p=32515699|t=2020. [The Agreed Experts' Position of the Eurasian Association of Therapists on Some new Mechanisms of COVID-19 Pathways: Focus on Hemostasis, Hemotransfusion Issues and Blood gas Exchange].|pdf=|usr=008}}
 +
{{tp|p=32526092|t=2020. Thromboprophylaxis in a patient with COVID-19 and severe hemophilia A on emicizumab prophylaxis.|pdf=|usr=008}}
 +
{{tp|p=32526058|t=2020. Response to 'all these D-dimers in COVID-19'.|pdf=|usr=008}}
 +
{{tp|p=32531536|t=2020. Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?|pdf=|usr=008}}
 +
{{tp|p=32529517|t=2020. Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment.|pdf=|usr=008}}
 +
{{tp|p=31471666|t=2019. Rivaroxaban and Aspirin in Peripheral Vascular Disease: a Review of Implementation Strategies and Management of Common Clinical Scenarios.|pdf=|usr=008}}
 +
{{tp|p=32509485|t=2020. Coronavirus Disease 2019 (COVID-19) Infection Associated With Antiphospholipid Antibodies and Four-Extremity Deep Vein thrombosis in a Previously Healthy Female.|pdf=|usr=008}}
 +
{{tp|p=32487231|t=2020. Severe pulmonary embolism in COVID-19 patients: a call for increased awareness.|pdf=|usr=008}}
 +
{{tp|p=32487122|t=2020. Thrombotic and hemorrhagic events in critically ill COVID-19 patients: a French monocenter retrospective study.|pdf=|usr=008}}
 +
{{tp|p=32527297|t=2020. Severe Covid-19 disease: rather AVDS than ARDS?|pdf=|usr=008}}
 +
{{tp|p=32527286|t=2020. COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?|pdf=|usr=008}}
 +
{{tp|p=32522226|t=2020. Low molecular weight heparins in COVID-19 patients: beware of augmented renal clearance!|pdf=|usr=008}}
 +
{{tp|p=32530413|t=2020. Pulmonary Artery Embolism in COVID-19 Despite Thrombosis Prophylaxis.|pdf=|usr=008}}
 +
{{tp|p=32467443|t=2020. Coagulopathy of Coronavirus Disease 2019.|pdf=|usr=008}}
 +
{{tp|p=32396506|t=2020. COVID-19 and Acute Pulmonary Embolism in Postpartum Patient.|pdf=|usr=008}}
 +
{{tp|p=32396627|t=2020. Successful percutaneous thrombectomy in a patient with COVID-19 pneumonia and acute pulmonary embolism supported by extracorporeal membrane oxygenation.|pdf=|usr=008}}
 +
{{tp|p=32383737|t=2020. The tug-of-war between coagulopathy and anticoagulant agents in patients with COVID-19.|pdf=|usr=008}}
 +
{{tp|p=32523963|t=2020. Pulmonary embolism: yet another cause of hypoxaemic respiratory failure in COVID-19.|pdf=|usr=008}}
 +
{{tp|p=32523928|t=2020. D-dimer and C-reactive Protein Blood Levels Over Time Used to Predict Pulmonary Embolism in Two COVID-19 Patients.|pdf=|usr=008}}
 +
{{ttp|p=32489244|t=2020. Microthrombotic Complications of COVID-19 Are Likely Due to Embolism of Circulating Endothelial Derived Ultralarge Von Willebrand Factor (eULVWF) Decorated-Platelet Strings.|pdf=|usr=008}}
 +
{{tp|p=32523920|t=2020. COVID-19 and Pulmonary Embolism: Not a Coincidence.|pdf=|usr=008}}
 +
{{tp|p=32390931|t=2020. A Case of Coronavirus Disease 2019 With Concomitant Acute Cerebral Infarction and Deep Vein Thrombosis.|pdf=|usr=008}}
 +
{{tp|p=32398297|t=2020. Pulmonary embolism in patients with Covid-19 pneumonia.|pdf=|usr=008}}
 +
{{tp|p=32398294|t=2020. Venous thromboembolism in SARS-CoV-2 patients: only a problem in ventilated ICU patients, or is there more to it?|pdf=|usr=008}}
 +
{{tp|p=32399449|t=2020. Deep Vein Thrombosis and Pulmonary Embolism: Two Complications of COVID-19 Pneumonia?|pdf=|usr=008}}
 +
 
 +
 
 +
 
 +
{{tp|p=32493073|t=2020. COVID-19 Presented With Deep Vein Thrombosis: An Unusual Presenting.|pdf=|usr=008}}
 +
{{tp|p=32515336|t=2020. [Forhojet D-dimer og karakteristiske billeddiagnostiske fund hos patient med COVID-19].|pdf=|usr=008}}
 +
{{tp|p=32515339|t=2020. [Venous thromboembolism in patients with COVID-19].|pdf=|usr=008}}
 +
 
 +
{{tp|p=32530411|t=2020. Pulmonary Embolism in Covid-19. Coagulation Parameters, Close Monitoring to Prevent?|pdf=|usr=008}}

Aktuelle Version vom 12. September 2020, 17:21 Uhr

coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.

 D further streaming-in related content is here

Since there are many organ manifestations of Hypercoagulation, subcategorization and transcategorization was applied.

The unifying concept behind is Dysendotheliopathies with the components Coagulation /Microthrombi, proliferative or cytopathic obstructive Endotheliosis and mediator production as well as failure of the mitigating systems and secondary vasculitis.



  • papers on various thromboembolic manifestations


32281926 2020. COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET)
32347323 ä. Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation
32360371 ä. Thromboembolic events in patients with SARS-CoV-2
C7146714 ä. Incidence of thrombotic complications in critically ill ICU patients with COVID-19
32324101 2020. Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands
32133825 2020. Characteristics, causes, diagnosis and treatment of coagulation dysfunction in patients with COVID-19
32402423 2020. Ten key points that vascular doctors learned very quickly about COVID-19
32381264 2020. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis
32388068 2020. Thrombotic complications in critically ill patients with COVID 19
32291094 2020. Incidence of thrombotic complications in critically ill ICU patients with COVID-19
32374544 2020. Risque thrombotique veineux induit par le SARS-CoV-2 : prevalence, recommandations et perspectives



  • papers on Hypoxemia


32359410 ä. Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT
C7177114 2020. Hypoxia in COVID-19: Sign of Severity or Cause for Poor Outcomes
32376101 2020. Association Between Hypoxemia and Mortality in Patients With COVID-19



  • others


32462990 2020. COVID-19 complicated by pulmonary embolism treated with catheter directed thrombectomy.
32338320 ä. Covid-19 treatment update: follow the scientific evidence
32501145 2020. Venous thromboembolism in patients with COVID-19 (SARS-CoV-2 infection) - a position paper of the German Society of Angiology (DGA).
32459857 2020. D-dimer and mortality in COVID-19: a self-fulfilling prophecy or a pathophysiological clue?
32314950 2020. Society for Vascular Medicine (SVM) Leaders Respond to the COVID-19 Crisis.
32447301 2020. Coexistent COVID-19 pneumonia and pulmonary embolism: challenges in identifying dual pathology.
32455440 2020. Sars-CoV-2 Induced Coagulopathy and Prognosis in Hospitalized Patients: A Snapshot from Italy.
32396963 2020. SARS-2 Coronavirus-Associated Hemostatic Lung Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary Embolism?
32512587 2020. Bleeding and Bleeding Risk in COVID-19.
32463186 2020. Lungeembolisme ved covid-19.
32425013 2020. COVID-19 and coagulative axis: review of emerging aspects in a novel disease.
32469410 2020. Venous Thrombosis Among Critically Ill Patients With Coronavirus Disease 2019 (COVID-19).
32392741 2020. Clotting Factors in COVID-19: Epidemiological Association and Prognostic Values in Different Clinical Presentations in an Italian Cohort.
32447934 2020. [Clinical and coagulation characteristics in 7 patients with critical COVID-2019 pneumonia and acro-ischemia].
32395964 2020. Do's-and-don'ts bij COVID-19-coagulopathie.
32454268 2020. D-dimer in patients infected with COVID-19 and suspected pulmonary embolism.
32507399 2020. Tromboembolismo pulmonar y COVID-19: un cambio de paradigma.
32380898 2020. The "venous perspective" in Lombardia (Italy) during the first weeks of the COVID-19 epidemic.
32490886 2020. Is there a rationale for heparin use among severe COVID-19 patients?
32453702 2020. Procoagulatio, hypercoagulatio es fibrinolysis "shut down" kimutatasa ClotPro(R) viszkoelasztikus tesztek segitsegevel COVID-19-betegekben.
32427809 2020. Inflammatory and Coagulative Considerations for the Management of Orthopaedic Trauma Patients with COVID-19: A Review of the Current Evidence and Our Surgical Experience.
32426897 2020. Heparin - an old drug with multiple potential targets in Covid-19 therapy.
32415902 2020. Ibuprofen and thromboembolism in SARS-COV2.
32506364 2020. Hyperacute multi-organ thromboembolic storm in COVID-19: a case report.
32504449 2020. Diagnosis of venous and arterial thromboembolic events in COVID-19 virus-infected patients.
32464707 2020. Macrothrombosis and stroke in patients with mild Covid-19 infection.
32470213 2020. All those D-dimers in COVID-19.
32470207 2020. Frequency of lupus anticoagulant in Covid-19 patients.
32470198 2020. Clinical differentiation of anticoagulant and non-anticoagulant properties of heparin.
32470154 2020. Reply to 'Ibuprofen and thromboembolism in SARS-COV2'.
32470156 2020. The novel coronavirus disease (COVID-19) complicated by pulmonary embolism and acute respiratory distress syndrome.
32393875 2020. Coronavirus blood-clot mystery intensifies.
32497287 2020. Anticardiolipin antibodies and COVID-19-A case report from America.
32495985 2020. The association between D-dimers in COVID-19 patients and mortality remains beset of uncertainties.
32409435 2020. Coagulopathy in COVID-19.
32505779 2020. Could antiphospholipid antibodies contribute to coagulopathy in COVID-19?
32512349 2020. Clinically significant anticardiolipin antibodies associated with COVID-19.
32468942 2020. A matter of time: duration and choice of venous thromboprophylaxis in patients diagnosed with COVID-19.
32464676 2020. Haemostasis in Times of COVID-19.
32498097 2020. Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis.
32476551 2020. Challenges in COVID-19: is pulmonary thromboembolism related to overall severity?
32429774 2020. Anti-coagulant and anti-platelet therapy in the COVID-19 patient: a best practices quality initiative across a large health system.
32508034 2020. Predicted value of coagulation function for prognosis and admission time to negative RT-PCR detection in non-critical COVID-19 patients.

32508062 2020. COVID-19 critical illness pathophysiology driven by diffuse pulmonary thrombi and pulmonary endothelial dysfunction responsive to thrombolysis.


32432563 2020. Reporting of D-dimer data in COVID-19: some confusion and potential for misinformation.
32421381 2020. Deep Vein Thrombosis in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: Prevalence, Risk Factors, and Outcome.
32412320 2020. Extremely High Incidence of Lower Extremity Deep Venous Thrombosis in 48 Patients with Severe COVID-19 in Wuhan.
32508261 2020. Hypoalbuminemia, Coagulopathy and Vascular Disease in Covid-19.
32463538 2020. Excess out-of-hospital deaths during COVID-19 outbreak: evidence of pulmonary embolism as a main determinant.
32406381 2020. COVID-19: progression of disease and intravascular coagulation - present status and future perspectives.
32423903 2020. Thrombotic risk in COVID-19: a case series and case-control study.
32491074 2020. COVID-19 e Estado de Hipercoagulabilidade: Uma Nova Perspectiva Terapeutica.
32396903 2020. Venous Thromboembolism Complicated with COVID-19: What Do We Know So Far?
32500589 2020. Superficial thrombophlebitis in a patient with COVID 19: Heparin treatment after evaluation of D - Dimer: COVID 19 and Superficial thrombophlebitis.

32459672 2020. Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019.


32503799 2020. Abrupt deterioration and pulmonary embolism in COVID-19: a case report.
32452757 2020. Vascular injury and COVID-19-related mortality: What lies below the tip of the iceberg?
32512408 2020. The choice of intravenous thrombolysis for Acute Ischemic Stroke under COVID-19 infection.
32453688 2020. COVID-19, thromboembolic risk and thromboprophylaxis: learning lessons from the bedside, awaiting evidence.
32438458 2020. Molecular mechanisms for thrombosis risk in Black people: a role in excess mortality from COVID-19.
32425273 2020. Pulmonary embolism and Sars-Cov-2 infection: A new indication for surgical pulmonary endarterectomy?
32420615 2020. Dynamic relationship between D-dimer and COVID-19 severity.
32510975 2020. Thromboprophylaxis in COVID-19: Anti-FXa - The Missing Factor?
32383969 2020. Segmental Pulmonary Vascular Changes in COVID-19 Pneumonia.
32478611 2020. Reply to "Segmental Pulmonary Vascular Changes in COVID-19 Pneumonia".
32506683 2020. D-dimer triage for COVID-19.
32484901 2020. Re The source of elevated plasma D-dimer levels in COVID-19 infection.
32497248 2020. Pulmonary Artery Thrombectomy - A Life Saving Treatment in a Patient with Presumed COVID-19 complicated by a massive Pulmonary Embolus.
32484907 2020. Prevalence of Venous Thromboembolism in Critically Ill Patients with COVID-19.
32420614 2020. First COVID-19 maternal mortality in the UK associated with thrombotic complications.
32439704 2020. Covid-19 and thrombosis: what do we know about the risks and treatment?
32462179 2020. Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study.
32492712 2020. COVID and Coagulation: Bleeding and Thrombotic Manifestations of SARS-CoV2 Infection.
32425236 2020. Acute Pulmonary Embolism: An unseen villain in COVID-19.
32532932 2020. Should lCU COVID-19 patients empirically receive therapeutic doses of anticoagulant?
32532939 2020. The rationale for Low-Molecular Weight Heparin (LMWH) use in SARS-CoV-2 infection
32532948 2020. Clinical experience with therapeutic dose of Low-Molecular-Weight Heparin.
32497796 2020. Combination of thrombolytic and immunosuppressive therapy for coronavirus disease 2019: A case report.
32471650 2020. Acute pulmonary embolism in COVID-19 disease: Preliminary report on seven patients.
32435822 2020. Incidence of pulmonary embolism in patients with COVID-19.
32435823 2020. Prothrombotic phenotype in COVID-19 severe patients.
32405288 2020. Acute upper limb ischemia in a patient with COVID-19.
32440985 2020. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment.
32424482 2020. Systemic arterial thrombosis and acute mesenteric ischemia in a patient with COVID-19.
32415314 2020. Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19.
32447121 2020. Unheralded Lower Limb Threatening Ischemia in a COVID-19 Patient.

32422349 2020. Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection.


32514682 2020. Managing anticoagulation in the COVID-19 era between lockdown and reopening phases.
32504198 2020. The burden of thrombotic complications in critically ill patients with COVID-19: charting the uncharted.
32490908 2020. COVID-19 pneumonia: a risk factor for pulmonary thromboembolism?
32521707 2020. Non-Overt Coagulopathy in Non-ICU Patients with Mild to Moderate COVID-19 Pneumonia.
32479784 2020. High prevalence of deep vein thrombosis in mechanically ventilated COVID-19 patients.
32414622 2020. Intravenous Thrombolysis for Stroke in a COVID-19 Positive Filipino Patient, a Case Report.
32402522 2020. Prophylactic anticoagulant therapy for reducing the risk of stroke and other thrombotic events in COVID-19 patients.
32305883 2020. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past.
32362977 2020. Abnormal Hemostatic Parameters and Risk of Thromboembolism Among Patients With COVID-19 Infection.
32504450 2020. Dysfunctional Coagulation in COVID-19: From Cell to Bedside.
32452874 2020. Thrombosis and coagulopathy in COVID-19 patients requiring extracorporeal membrane oxygenation.
32474145 2020. COVID-19-Related Aortic Thrombosis: A Report of Four Cases.
32473304 2020. Abdominal Aortic Thrombosis Complicating COVID-19 Pneumonia.
32473303 2020. Inferior vena cava filter in a patient with COVID-19 pneumonia to prevent a massive pulmonary embolism.
32440663 2020. Pulmonary Thromboembolism as a Potential Cause of Clinical Deterioration in COVID-19 Patients; a Commentary.
32422061 2020. Thromboembolic Findings in COVID-19 Autopsies: Pulmonary Thrombosis or Embolism?
32422076 2020. Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series.
32425319 2020. COVID-19 infection with extensive thrombosis: A case of phlegmasia cerulea dolens.
32492443 2020. Right-to-left interatrial shunt in COVID-19 patients with pulmonary embolism.
32437961 2020. Coagulation changes and thromboembolic risk in COVID-19 pregnant patients.
32437586 2020. Understanding the COVID-19 coagulopathy spectrum.
32426575 2020. Clot in Transit on Transesophageal Echocardiography in a Prone Patient with COVID-19 Acute Respiratory Distress Syndrome.
32468143 2020. Heparin-Related Major Bleeding in Covid-19-Positive Patient: Perspective from the Outbreak.
32419077 2020. Spontaneous Bleedings in COVID-19 Patients: An Emerging Complication.
32417209 2020. Thrombocytopenia and coagulation disorders due to COVID 19 infection with concomitant cardiovascular diseases requiring anti-platelet and anticoagulant therapy, which strategy?
32516478 2020. Severe bleeding in a patient with Factor XIII deficiency and COVID-19.
32301349 2020. Cost-effectiveness of rivaroxaban plus aspirin (dual pathway inhibition) for prevention of ischaemic events in patients with cardiovascular disease: on top optimisation of secondary prevention medication in the context of COVID-19 pandemia.
32445671 2020. Can Ticagrelor be used to prevent sepsis-induced coagulopathy in COVID-19?
32400024 2020. More on COVID-19 coagulopathy in Caucasian patients.
32392353 2020. More on: 'COVID-19 coagulopathy in Caucasian patients'.
32500226 2020. Antiphospholipid antibodies in patient with acute lower member ischemia and pulmonary thromboembolism as a result of infection by SARS-CoV2.
32529774 2020. High Frequency of Antiphospholipid Antibodies in Critically-ill COVID-19 Patients: a Link with Hypercoagulability?
32515699 2020. [The Agreed Experts' Position of the Eurasian Association of Therapists on Some new Mechanisms of COVID-19 Pathways: Focus on Hemostasis, Hemotransfusion Issues and Blood gas Exchange].
32526092 2020. Thromboprophylaxis in a patient with COVID-19 and severe hemophilia A on emicizumab prophylaxis.
32526058 2020. Response to 'all these D-dimers in COVID-19'.
32531536 2020. Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?
32529517 2020. Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment.
31471666 2019. Rivaroxaban and Aspirin in Peripheral Vascular Disease: a Review of Implementation Strategies and Management of Common Clinical Scenarios.
32509485 2020. Coronavirus Disease 2019 (COVID-19) Infection Associated With Antiphospholipid Antibodies and Four-Extremity Deep Vein thrombosis in a Previously Healthy Female.
32487231 2020. Severe pulmonary embolism in COVID-19 patients: a call for increased awareness.
32487122 2020. Thrombotic and hemorrhagic events in critically ill COVID-19 patients: a French monocenter retrospective study.
32527297 2020. Severe Covid-19 disease: rather AVDS than ARDS?
32527286 2020. COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?
32522226 2020. Low molecular weight heparins in COVID-19 patients: beware of augmented renal clearance!
32530413 2020. Pulmonary Artery Embolism in COVID-19 Despite Thrombosis Prophylaxis.
32467443 2020. Coagulopathy of Coronavirus Disease 2019.
32396506 2020. COVID-19 and Acute Pulmonary Embolism in Postpartum Patient.
32396627 2020. Successful percutaneous thrombectomy in a patient with COVID-19 pneumonia and acute pulmonary embolism supported by extracorporeal membrane oxygenation.
32383737 2020. The tug-of-war between coagulopathy and anticoagulant agents in patients with COVID-19.
32523963 2020. Pulmonary embolism: yet another cause of hypoxaemic respiratory failure in COVID-19.
32523928 2020. D-dimer and C-reactive Protein Blood Levels Over Time Used to Predict Pulmonary Embolism in Two COVID-19 Patients.

32489244 2020. Microthrombotic Complications of COVID-19 Are Likely Due to Embolism of Circulating Endothelial Derived Ultralarge Von Willebrand Factor (eULVWF) Decorated-Platelet Strings.


32523920 2020. COVID-19 and Pulmonary Embolism: Not a Coincidence.
32390931 2020. A Case of Coronavirus Disease 2019 With Concomitant Acute Cerebral Infarction and Deep Vein Thrombosis.
32398297 2020. Pulmonary embolism in patients with Covid-19 pneumonia.
32398294 2020. Venous thromboembolism in SARS-CoV-2 patients: only a problem in ventilated ICU patients, or is there more to it?
32399449 2020. Deep Vein Thrombosis and Pulmonary Embolism: Two Complications of COVID-19 Pneumonia?



32493073 2020. COVID-19 Presented With Deep Vein Thrombosis: An Unusual Presenting.
32515336 2020. [Forhojet D-dimer og karakteristiske billeddiagnostiske fund hos patient med COVID-19].
32515339 2020. [Venous thromboembolism in patients with COVID-19].


32530411 2020. Pulmonary Embolism in Covid-19. Coagulation Parameters, Close Monitoring to Prevent?

Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge
Blogverzeichnis - Blog Verzeichnis bloggerei.deBlogverzeichnis